scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1055/S-2007-992923 |
P698 | PubMed publication ID | 18181081 |
P2093 | author name string | Anuja Dokras | |
P433 | issue | 1 | |
P921 | main subject | cardiovascular disease | Q389735 |
polycystic ovary syndrome | Q500816 | ||
polycystic ovary | Q5547896 | ||
P304 | page(s) | 39-44 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Seminars in Reproductive Medicine | Q15724536 |
P1476 | title | Cardiovascular disease risk factors in polycystic ovary syndrome | |
P478 | volume | 26 |
Q26822385 | Associations between TNF-α and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis |
Q51281730 | Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study. |
Q51373655 | Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. |
Q36795530 | Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Q36896732 | Carotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal Hyperplasia |
Q36058191 | Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. |
Q37251943 | Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism |
Q47212737 | Correlations Between Anthropometry and Lipid Profile in Women With PCOS. |
Q61439146 | Dietary underreporting in women affected by polycystic ovary syndrome: A pilot study |
Q90588144 | Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS |
Q39503792 | Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome. |
Q51236725 | Effects of vitamin D3 derivative--calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model. |
Q37253000 | HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome? |
Q61515666 | Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome |
Q85090007 | Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients |
Q87071021 | Localization of the Trace Elements Iron, Zinc and Selenium in Relation to Anatomical Structures in Bovine Ovaries by X-Ray Fluorescence Imaging |
Q64921252 | Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome. |
Q45392415 | Lower-limb veins are thicker and vascular reactivity is decreased in a rat PCOS model: concomitant vitamin D3 treatment partially prevents these changes. |
Q35244129 | Mental health and physical activity in women with polycystic ovary syndrome: a brief review |
Q37489471 | Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome. |
Q82419051 | Obesity and polycystic ovary syndrome |
Q51337942 | Pharmacological reactivity of resistance vessels in a rat PCOS model - vascular effects of parallel vitamin D₃ treatment. |
Q37625653 | Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis |
Q83062366 | Polycystic ovary syndrome |
Q51411759 | Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis. |
Q33789151 | Statins in the treatment of polycystic ovary syndrome |
Q41856851 | Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. |
Q50866777 | The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome. |
Q24234635 | Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women |
Search more.